The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...

Nearly 4 million patients with chronic obstructive pulmonary disease (COPD) or asthma die each year, mostly from severe acute ...

For this reason, ipratropium was not recommended in asthma, except in acute severe asthma management. Tiotropium, the first-choice long-acting bronchodilator in COPD, has been studied in severe ...

Asthma is a heterogeneous disease more ... processes affect the bronchial milieu and predispose to acute and occasionally severe clinical manifestations. The complexity underlying these episodes ...

A drug already used in the treatment of severe asthma could help treat exacerbations in asthma and COPD, a UK trial has found ...

If you have asthma or severe asthma, consider adding the following foods and nutrients to your diet: Scientists have extensively investigated vitamin C, vitamin E, and vitamin A/beta carotene for ...

A new study testing the efficacy of antibody injections as a treatment for severe asthma has yielded promising results. But ...

It included 158 patients, randomly assigned treatment at the point of acute eosinophilic exacerbation ... Fasenra is approved for the treatment of severe eosinophilic asthma (SEA), administered ...

Stanley Fineman, MD, MBA First of all, asthma is a potentially life threatening situation when you have a severe acute attack. It closes the airways and makes people feel like they are breathing ...

For the first time in five decades, researchers have identified a groundbreaking treatment for asthma attacks. The new ...

The results demonstrate the safety and efficacy of Fasenra in the treatment of acute eosinophilic exacerbations in asthma and ...

GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of phase 3 trials presented at the European Respiratory Society (ERS ...